New IgA nephropathy drug shows early promise in small trial
Disease control
Completed
This study tested a new drug called XH-S003 in 25 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage, after 90 days. Participants had to have a kidney biopsy confirming the disease. T…
Phase: PHASE2 • Sponsor: S-INFINITY Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC